Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.
复制标题
DOI:
10.1002/hep.27362
复制
发表时间:
2014-12
期刊:
影响因子:
13.5
通讯作者:
Sirlin, Claude
中科院分区:
文献类型:
--
作者:
Loomba, Rohit;Wolfson, Tanya;Ang, Brandon;Hooker, Jonathan;Behling, Cynthia;Peterson, Michael;Valasek, Mark;Lin, Grace;Brenner, David;Gamst, Anthony;Ehman, Richard;Sirlin, Claude
Retrospective studies have shown that two-dimensional magnetic resonance elastography (2D-MRE), a novel MR method for assessment of liver stiffness, correlates with advanced fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Prospective data on diagnostic accuracy of 2D-MRE in the detection of advanced fibrosis in NAFLD are needed. The aim of this study is to prospectively assess the diagnostic accuracy of 2D-MRE, a noninvasive imaging biomarker, in predicting advanced fibrosis (stage 3 or 4) in well-characterized patients with biopsy-proven NAFLD. This is a cross-sectional analysis of a prospective study including 117 consecutive patients (56% women) with biopsy-proven NAFLD who underwent a standardized research visit: history, exam, liver biopsy assessment (using the nonalcoholic steatohepatitis Clinical Research Network histological scoring system), and 2D-MRE from 2011 to 2013. The radiologist and pathologist were blinded to clinical and pathology/imaging data, respectively. Receiver operating characteristics (ROCs) were examined to assess the diagnostic test performance of 2D-MRE in predicting advanced fibrosis. The mean (± standard deviation) of age and body mass index was 50.1 (± 13.4) years and 32.4 (± 5.0) kg/m2, respectively. The median time interval between biopsy and 2D-MRE was 45 days (interquartile range: 50 days). The number of patients with fibrosis stages 0, 1, 2, 3, and 4 was 43, 39, 13, 12, and 10, respectively. The area under the ROC curve for 2D-MRE discriminating advanced fibrosis (stage 3-4) from stage 0-2 fibrosis was 0.924 (P < 0.0001). A threshold of >3.63 kPa had a sensitivity of 0.86 (95% confidence interval [CI]: 0.65-0.97), specificity of 0.91 (95% CI: 0.83-0.96), positive predictive value of 0.68 (95% CI: 0.48-0.84), and negative predictive value of 0.97 (95% CI: 0.91-0.99). Conclusions: MRE is accurate in predicting advanced fibrosis and may be utilized for noninvasive diagnosis of advanced fibrosis in patients with NAFLD. (Hepatology 2014;60:1920–1928)
登录
查看更多内容
影响因子:
2.3
作者:
DITTRICH, M;MILDE, S;WEITZEL, D
通讯作者:
WEITZEL, D
影响因子:
3.7
作者:
Kim SU;Lee JH;Kim DY;Ahn SH;Jung KS;Choi EH;Park YN;Han KH;Chon CY;Park JY
通讯作者:
Park JY
影响因子:
168.9
作者:
Imbert-Bismut, F;Ratziu, V;Poynard, T
通讯作者:
Poynard, T
影响因子:
19.7
作者:
HANLEY, JA;MCNEIL, BJ
通讯作者:
MCNEIL, BJ
影响因子:
13.5
作者:
Jung, Kyu Sik;Kim, Seung Up;Han, Kwang-Hyub
通讯作者:
Han, Kwang-Hyub